Takeda Pharmaceutical Co., Ltd.
(NYSE : TAK)

( )
TAK PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. 3.04%92.771.9%$1227.50m
JNJJohnson & Johnson 1.11%148.600.7%$1059.48m
BMYBristol-Myers Squibb Co. -0.15%59.721.0%$1024.94m
PFEPfizer Inc. -0.16%38.120.9%$854.75m
MRKMerck & Co., Inc. 2.10%80.700.7%$839.97m
LLYEli Lilly & Co. 1.71%153.221.1%$505.05m
AZNAstraZeneca Plc 2.04%54.591.2%$279.84m
NVSNovartis AG 1.39%87.480.2%$155.07m
GSKGlaxoSmithKline Plc 0.96%41.940.2%$138.99m
NVONovo Nordisk A/S 1.52%65.950.1%$91.79m
SNYSanofi 0.88%49.110.2%$75.33m
RGENRepligen Corp. 1.36%130.977.1%$69.36m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 8.29%62.590.0%$47.83m
TPTXTurning Point Therapeutics, Inc. 0.99%69.250.0%$40.47m
ARCTArcturus Therapeutics Holdings, Inc. 5.99%38.940.0%$37.16m

Company Profile

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.